http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2538925-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
filingDate 2011-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_609dfce8f51f0318d516fecdf2c82fe4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2ba6e245fddb25eead7ed9d3ffd5c24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32cc7c0f5ee3063a30d0beeb70cfbe3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbab37c5f8c2e05bf928d18dc1d999ce
publicationDate 2013-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2538925-A2
titleOfInvention Apixaban formulations
abstract Compositions comprising crystalline apixaban particles having a D 90 equal to or less than 89 μm, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to for the treatment and/or prophylaxis of thromboembolic disorders.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3017811-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3246021-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3251660-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3257500-B1
priorityDate 2010-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91148840
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10182969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245949121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245521420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226490001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448380735

Total number of triples: 57.